Cohance Lifesciences Ltd.

₹867.0

Cohance Lifesciences Ltd.

Add Alert
Add Watchlist

₹867.0

₹867.0

-18.4 (-2.08%) - 14 Oct 2025 04:22 PM

About Company

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Market Cap. ₹ 33,169 Cr.
52 Week - High/Low ₹ 1,360/916
P/E Ratio 95.24
P/B Ratio 14.95
Enterprise Value ₹ 34,649 Cr.
ROE % 12.56
RSI Value 41.08
EMA 50 924.99
EMA 200 968.81
Market Cap. ₹ 33,169 Cr.
52 Week - High/Low ₹ 1,360/916
P/E Ratio 96.05
P/B Ratio 20.40
Enterprise Value ₹ 35,349 Cr.
ROE % 14.2
RSI Value 41.08
EMA 50 924.99
EMA 200 968.81

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.